The Food and Drug Administration announced plans to survey doctors, nurse practitioners and physician assistants on their awareness and perception of direct-to-consumer prescription drug advertising. The agency is seeking comment on a proposed survey of 2,000 healthcare professionals, according to a notice scheduled to appear in the Federal Register (PDF).
FDA plans survey on direct-to-consumer drug ads
The agency’s prior survey in 2002, which included doctors and patients, found doctors’ opinions divided on the influence of drug advertising directed at consumers, according to the notice. “The question of whether a similar pattern will emerge now, despite the growth of DTC advertising, is a vital one,” the notice said. “Furthermore, FDA will benefit from knowing more detail about the various type s of perceived effects DTC advertising might have.”
The proposed survey would be nationally representative and include 1,000 general practice and specialist physicians, 500 nurse practitioners and 500 physician assistants. The survey will also include questions about social media, online marketing and office detailing.
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.